Viewing Study NCT00592969


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-01-05 @ 2:30 AM
Study NCT ID: NCT00592969
Status: COMPLETED
Last Update Posted: 2017-02-24
First Post: 2008-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module